Optimizing transcatheter therapies for hepatocellular carcinoma: invited editorial regarding “Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial”

Shi et al. recently published a 3 arm randomized study comparing efficacy and safety of 3 different modes of intra-arterial chemotherapy infusion and embolization (1). This study adds to the growing, yet sometimes confusing literature regarding transcatheter therapies for hepatocellular carcinoma (HCC). Although the literature is growing, unfortunately randomized and prospective trials are relatively sparse.